Affiliations 

  • 1 Department of Structural Cardiology, Shandong Second Provincial General Hospital, Jinan, Shandong Province, 250000, China. [email protected]
  • 2 Department of Pharmacy, State University of Bangladesh, 77 Satmasjid Road, Dhanmandi, Dhaka 1205, Bangladesh. [email protected]
  • 3 Department of Pharmacy, State University of Bangladesh, 77 Satmasjid Road, Dhanmandi, Dhaka 1205, Bangladesh. [email protected]
  • 4 Department of Pharmacy, State University of Bangladesh, 77 Satmasjid Road, Dhanmandi, Dhaka 1205, Bangladesh. [email protected]
  • 5 Drugs and Toxins Research Division, BCSIR Laboratories Rajshahi, Bangladesh Council of Scientific and Industrial Research, Rajshahi 6206, Bangladesh. [email protected]
  • 6 Biochemistry and Molecular Biology, Upstate Medical University, New York, 132104, United States. [email protected]
  • 7 Department of Pharmacy, University of Asia Pacific, 74/A, Green Road, Dhaka- 1205, Bangladesh. [email protected]
  • 8 Centre for Sustainability of Ecosystem and Earth Resources (Pusat ALAM), Universiti Malaysia Pahang, 26300 Kuantan, Malaysia. [email protected]
  • 9 School of Medical and Life Sciences, Sunway University, Sunway City 47500, Malaysia. [email protected]
  • 10 Department of Pharmacy, University of Asia Pacific, 74/A, Green Road, Dhaka- 1205, Bangladesh. [email protected]
  • 11 Department of Pharmaceutical Sciences, College of Pharmacy, Mercer University, Atlanta, GA 30341, United States. [email protected]
Cell Mol Biol (Noisy-le-grand), 2022 Sep 30;68(9):1-13.
PMID: 36905282 DOI: 10.14715/cmb/2022.68.9.1

Abstract

Piper betle L. leaves are very popular and traditionally used to chew with betel nut in many Asian countries. In this study, P. betle leaves juice (PBJ) was subjected to evaluation for its antihyperlipidemic activity in the high-fat-diet-induced hyperlipidemic rats model. Swiss albino rats were allowed to high-fat- diet for one month, followed by concurrent administration of PBJ for another month. The rats were then sacrificed and collected blood, tissues and organs. Pharmacokinetic, toxicological studies and molecular docking studies were performed using SwissADME, admetSAR and schrodinger suit-2017. Our investigation showed a promising effect of PBJ on body weight, lipid profile, oxidative and antioxidative enzymes, and the principle enzyme responsible for the synthesis of cholesterol. PBJ at 0.5 - 3.0 mL/rat significantly reduced body weight of hyperlipidemic rats compared to control. PBJ at the doses of 1.0, 1.5, 2.0, and 3.0 mL/rat significantly (p<0.05, p<0.01, p<0.001) improved the levels of TC, LDL-c, TG, HDL-c and VLDL-c. Similarly, PBJ doses starting from 1.0 mL/rat to 3.0 mL/rat reduced the oxidative biomarkers AST, ALT, ALP, and creatinine. The level of HMG-CoA was significantly reduced by PBJ doses 1.5, 2, and 3 ml/rat. A number of compounds have been found to have good pharmacokinetic profile and safety and 4-coumaroylquinic acid exerted the best docking score among them. Thus our findings clearly demonstrated the potential lipid-lowering activities of PBJ both in vivo and in silico studies. PBJ can be a good candidate for the development of antihyperlipidemic medication or as an alternative medicine.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.